#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Post transplant lymphoproliferative disorder Colon cancer Acute myeloid leukaemia Thrombocytopenia Bile acid synthesis disorder Pericarditis Ovarian cancer Small cell lung cancer recurrent Cortical dysplasia Hidradenitis Infertility male Vulval cancer Tourette's disorder Glomerulonephritis acute More trials…

    Learn about Rare Diseases

    Proteus syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Alport’s syndrome – Trials in Disease Amyotrophic lateral sclerosis – Diagnostics Hairy cell leukaemia – Trials in Disease Netherton’s syndrome – Diagnostics Lymphangioma – Diagnostics Haemophilia A with anti factor VIII – Treatment Medulloblastoma recurrent – Trials in Disease Crigler-Najjar syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Itolizumab Etoposide Phosphate Indacaterol Maleate Arachis Hypogaea Extract Lutetium (177Lu) Oxodotreotide Levothyroxine Cobolimab GUAIACOL Io103 Acetate ALG-000184 LY3841136 SODIUM Petosemtamab ROC-101 HYDROCHLORIDE Opevesostat VG801-1 Lixudebart Cedazuridine Elivaldogene Autotemcel Etrasimod Arginine Cortisone Acetate More therapies…

    Learn about Your Condition

    Myotonia Mantle cell lymphoma recurrent Elderly Depression Neuroendocrine carcinoma Spinal cord injury Hodgkin's disease recurrent Pseudomonas infection Mucopolysaccharidosis Pneumococcal infection Osteoarthritis Delayed graft function Laryngeal cancer stage I Actinic cheilitis Chronic hepatitis B More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Chronic lymphocytic leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • IDP-121
    Spain

  • Study on the Effectiveness and Safety of Bortezomib and Daratumumab for Patients with Primary Plasma Cell Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Cyclophosphamide
    • Daratumumab
    Greece

  • Study on the Effects of BT200 (Rondaptivon Pegol) for Patients with Type 2B von Willebrand Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Von Willebrand’s disease
    Investigated Drugs:
    • Rondaptivon Pegol
    Austria

  • Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France Germany Italy The Netherlands Spain

  • Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Nivolumab
    Italy Poland Spain

  • Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Ddcart‐Cd19
    • Cyclophosphamide
    • Fludarabine Phosphate
    Greece
Previous Page
1 … 13 14 15 16 17 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!